Table 4.
Endorsement of ESC clinical guidelines and implementation of cardiovascular and stroke-specific prevention initiatives. Country assessment
| Country | Addressing cardiovascular disease prevention
|
||||||
|---|---|---|---|---|---|---|---|
| 2016 ESC Guidelines clinical practice* | Initiatives to raise stroke awareness | Stroke registries | 2016 ESC Guidelines on management of AF* | Screening for atrial fibrillation# | 2013 ESC Guidelines on management of arterial hypertension* | Screening for blood pressure# | |
| Belgium | Yes | 1 | 0 | Yes | 12% | Yes | 28% |
| France | Yes | 0 | 0 | Yes | 15% | Yes | 30% |
| Germany | Yes | 0 | 1 | No | 13% | Yes | 16% |
| Italy | Yes | 2 | 0 | Yes | 17% | No | 14% |
| The Netherlands | Yes | 0 | 0 | No | 5% | No | 10% |
| Norway | No | 0 | 0 | No | 18% | Yes | 19% |
| Russia | Yes | 0 | 1 | Yes | 42% | Yes | 23% |
| Spain | Yes | 0 | 0 | Yes | 12% | Yes | 8% |
| Sweden | Yes | 0 | 1 | Yes | 19% | No | 22% |
| Turkey | Yes | 0 | 0 | Yes | 13% | Yes | 13% |
| UK | Yes | 2 | 2∞ | Yes | 8% | No | 11% |
Notes:
*
As indicated on ESC member national cardiac society websites. Yes/no shows whether or not the national society has endorsed the ESC clinical practice guideline.17
#
% of patients screened as described in Table 1.
∞
The UK registry covers England, Northern Ireland, and Wales; however Scotland has its own stroke registry.
Abbreviation: ESC, European Society of Cardiology.